防移位全覆膜金属支架治疗儿童主导性胰管狭窄的长期结局:与成人对比分析
该回顾性研究纳入85例慢性胰腺炎伴良性主导性胰管狭窄患者(儿童31例、成人54例),评估带锚定瓣的防移位全覆膜自膨式金属支架(FCSEMS)的长期结局。两组技术成功率均为100%且无支架移位,临床成功率和狭窄缓解率相当,儿童支架交换更频繁;探索性经济分析显示FCSEMS较塑料支架策略在两组均节省费用。
要点
- 防移位FCSEMS在儿童和成人慢性胰腺炎主导性胰管狭窄中技术成功率达100%且无移位。
- 儿童患者支架交换次数中位数4次,多于成人的2次(P<.001)。
- 从诊断至FCSEMS置入间隔每延长1年,复发风险增加(HR 1.44,95%CI 1.22-1.70)。
核心结论
- 防移位FCSEMS在选定的儿童和成人慢性胰腺炎主导性主胰管狭窄患者中技术可行,无支架移位且不良事件率低。
- 探索性经济分析显示FCSEMS较塑料支架策略在儿童和成人两组均节省费用,对以内镜治疗为主要手段的儿童患者尤为有利。
研究设计与样本
- 韩国Asan Medical Center开展的回顾性分析,纳入85例连续慢性胰腺炎伴良性主导性胰管狭窄并置入带锚定瓣FCSEMS的患者,其中儿童31例、成人54例。
- 评估临床结局与狭窄复发,并以韩国国民健康保险体系视角、采用两种互补建模方法进行FCSEMS与塑料支架策略的探索性经济分析。
主要发现
- 两组技术成功率均为100%,均无支架移位。
- 临床成功率儿童90.3% vs 成人77.8%(P=.10),狭窄缓解率儿童96.8% vs 成人90.7%(P=.29),两组相当。
- 儿童患者支架交换更频繁(中位数4次 vs 2次,P<.001),且每根支架留置时间更短。
- 复发率儿童23.3%、成人34.7%。
- 校正年龄组后,从症状性主导性主胰管狭窄诊断至FCSEMS置入的间隔越长,复发时间越短(每增加1年HR 1.44,95%CI 1.22-1.70,P<.001),提示早期(≤1年)置入FCSEMS可能带来有利结局。
关键数值与推荐
- 技术成功定义为FCSEMS置入成功,两组均为100%。
- 临床成功儿童90.3%、成人77.8%(P=.10);狭窄缓解儿童96.8%、成人90.7%(P=.29)。
- 支架交换次数中位数儿童4次、成人2次(P<.001)。
- 复发率儿童23.3%、成人34.7%。
- 探索性经济分析显示FCSEMS较塑料支架策略每例患者节省费用:儿童2125美元、成人2299美元,归因于ERCP次数减少。
临床怎么用
- 对选定的慢性胰腺炎主导性主胰管狭窄儿童和成人患者,可考虑使用带锚定瓣的防移位FCSEMS以降低移位风险。
- 诊断至FCSEMS置入间隔较长与复发时间缩短相关,提示在诊断后1年内较早置入可能改善结局。
- 儿童患者需预期更频繁的支架交换和更短的每根支架留置时间,并据此安排随访。
- FCSEMS策略可能通过减少ERCP次数降低总体医疗费用,尤其对儿童患者。
局限性
- 本研究为单中心回顾性分析,样本量有限(共85例)。
- 经济分析为探索性,基于韩国国民健康保险体系视角和建模假设,外推需谨慎。
- 研究未设前瞻性对照,FCSEMS与塑料支架的比较仅通过建模进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The use of fully covered self-expandable metal stents (FCSEMSs) in chronic pancreatitis (CP) remains limited because of stent migration concerns. We evaluated long-term outcomes of antimigration FCSEMSs in pediatric and adult patients with CP and explored their procedural economic implications. METHODS: We retrospectively analyzed 85 consecutive patients (31 pediatric and 54 adult) with CP and benign dominant pancreatic duct strictures who underwent placement of an FCSEMS with anchoring flaps at Asan Medical Center, South Korea. Clinical outcomes and stricture recurrence were evaluated. An exploratory economic analysis comparing FCSEMS with a plastic stent strategy was performed from the perspective of the Korean National Health Insurance system using 2 complementary modeling approaches. RESULTS: Technical success was 100% in both groups, with no migration. Clinical success (90.3% vs 77.8%, P = .10) and stricture resolution (96.8% vs 90.7%, P = .29) were comparable between cohorts. Pediatric patients underwent more frequent stent exchanges (median 4 vs 2, P < .001) and shorter per-stent indwelling durations. Recurrence occurred in 23.3% of pediatric and 34.7% of adult patients. In the pooled analysis adjusted for age group, a longer interval from symptomatic dominant main pancreatic duct (MPD) stricture diagnosis to FCSEMS insertion was independently associated with shorter time to recurrence (hazard ratio [HR], 1.44 per 1-year increase; 95% CI, 1.22-1.70; P < .001), suggesting that earlier FCSEMS placement (≤1 year) may lead to favorable outcomes. Exploratory economic analysis showed cost savings with FCSEMS over a plastic stent strategy in both cohorts (per-patient savings: $2125 pediatric, $2299 adult), driven by reduced ERCP session frequency. CONCLUSIONS: Antimigration FCSEMSs appear technically feasible for selected pediatric and adult patients with dominant MPD strictures in CP, with no migration and low adverse event rates. Exploratory economic analysis demonstrated cost savings in both cohorts, with particularly favorable implications for pediatric patients, in whom endoscopic therapy remains the primary modality.
引用
- Song YJ, Huh G, Kim KM, et al. Long-term outcomes of antimigration fully covered metal stents for dominant pancreatic duct strictures in children: a comparative analysis with adults. Gastrointest Endosc. 2026. PMID: 42342046. doi:10.1016/j.gie.2026.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。